Rare
lephants
Screener
Toggle theme
Rigel Pharmaceuticals, Inc.
RIGL
·
Healthcare, Drug Manufacturers - General, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
EPS
Sales Per Share
Book Per Share
FCF Per Share
Dividend Per Share
Shares Outstanding
Share-Based Metrics
›
Sales Per Share
Compare
←
5Y
10Y
MAX
→
Sales Per Share
Chart
Table
Fiscal Year
Sales Per Share
FY2022
$7.05
FY2023
$6.72
FY2024
$10.14
FY2025
$15.62
Download CSV
